Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros

Medicinas Complementares
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Transplant Proc ; 44(9): 2551-4, 2012 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-23146451

RESUMO

INTRODUCTION: Persistence of inappropriately high serum levels of fibroblast growth factor-23 (FGF23), a recently discovered phosphaturic hormone, has been reported to play an important role in the pathogenesis of posttransplant hypophosphatemia. The aim of the present study was to evaluate FGF23 in the early posttransplant period and study the complex associations between FGF23, parathyroid hormone (PTH), 1,25(OH)(2) vitamin D, and phosphate in transplant patients. MATERIALS AND METHODS: We performed a cross-sectional observational study of 42 adult kidney recipients in the early posttransplant period (<6 months). Fasting serum samples and 24-hour urine samples were collected during a routine follow-up outpatient visit. Serum creatinine, calcium, phosphate, magnesium and urinary creatinine, calcium, magnesium, and phosphate were measured using standard assays. We also studied concentrations of 25 hydroxyvitamin D, 1,25(OH)(2) vitamin D, intact PTH, and circulating FGF23. RESULTS: Median values for the different parameters studied were as follows: 9.9 ± 0.6 mg/dL, phosphatemia 3.3 ± 0.7 mg/dL, estimated glomerular filtration rate (eGFR; 41.1 ± 14.0 mL/min, phosphate reabsorption rate 68.4% ± 10.7%, PTH 94.5 ng/L (53.8-199.5), calcitriol 33.0 pg/mL (24.0-44.1), calcidiol 27.3 ng/mL (17.0-38.0), FGF23 139 pg/mL (88-221), and calciuria 62.5 mg/d (40.3-101.3). The variables significantly associated with serum FGF23 levels were phosphate reabsorption rate (r = .493; P = .001), calcitriol (r = .399; P = .009), eGFR (r = .557; P < .001), PTH (0.349; P = .024). CONCLUSIONS: Elevated serum levels of FGF23 could explain the deficiency of calcitriol and elevated renal phosphorus wasting in the early posttransplant period. All treatments that can lead to increased serum phosphate levels (eg, oral medication or calcitriol) should be carefully evaluated, since increased phosphatemia could further stimulate secretion of FGF23 and prolong high phosphorus loss.


Assuntos
Cálcio/sangue , Fatores de Crescimento de Fibroblastos/sangue , Hipofosfatemia/etiologia , Transplante de Rim/efeitos adversos , Fósforo/sangue , Biomarcadores/sangue , Biomarcadores/urina , Cálcio/urina , Distribuição de Qui-Quadrado , Estudos Transversais , Fator de Crescimento de Fibroblastos 23 , Taxa de Filtração Glomerular , Humanos , Hipofosfatemia/sangue , Hipofosfatemia/fisiopatologia , Hipofosfatemia/terapia , Hipofosfatemia/urina , Hormônio Paratireóideo/sangue , Fósforo/urina , Fatores de Tempo , Regulação para Cima , Vitamina D/análogos & derivados , Vitamina D/sangue
3.
Rev Esp Quimioter ; 23(2): 103-8, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20559610

RESUMO

Acinetobacter baumannii are emerging as the causal agents of healthcare-associated infections. We describe arenal transplant recipient who developed bacteremia caused by multiresistant A. baumannii, which received a combination of tigecycline, colistin, and meropenem in continuous infusion. The clinical outcome was favorable. In this article we made a molecular study of this multiresistant strain. Our analysis reveals the presence of abla-OXA-72 gene,a class D of oxacillinase belonging to bla-OXA-40-like group,which constitutes the most disseminated familiy of carbapenemases in Spain. Thus, we found different susceptibility patterns of A. baumannii when we used different Mueller-Hinton agars with different manganese concentrations. Lastly, we explain the combination of these three antibiotics administered to increase microbiologic and pharmacodynamic yield.


Assuntos
Infecções por Acinetobacter/tratamento farmacológico , Infecções por Acinetobacter/microbiologia , Acinetobacter baumannii/efeitos dos fármacos , Antibacterianos/uso terapêutico , Colistina/uso terapêutico , Transplante de Rim/fisiologia , Minociclina/análogos & derivados , Tienamicinas/uso terapêutico , Acinetobacter baumannii/genética , Idoso , Antibacterianos/farmacologia , Colistina/farmacologia , Combinação de Medicamentos , Farmacorresistência Bacteriana Múltipla , Feminino , Humanos , Falência Renal Crônica/complicações , Falência Renal Crônica/cirurgia , Meropeném , Testes de Sensibilidade Microbiana , Minociclina/farmacologia , Minociclina/uso terapêutico , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Tienamicinas/farmacologia , Tigeciclina
4.
Nefrología (Madr.) ; 21(6): 596-600, nov.-dic. 2001.
Artigo em Espanhol | IBECS | ID: ibc-126485

RESUMO

La calcifilaxia es un proceso poco frecuente pero grave, descrito mayoritariamente en pacientes con insuficiencia renal, y que se caracteriza por la calcificación de arteriolas dérmicas, que puede llevar a la ulceración con necrosis e isquemia de la piel. Los mecanismos implicados en su patogenia han evolucionado. Aunque existe controversia, el producto calcio-fósforo elevado es el determinante individual más relevante, aunque no de manera universal. Dada la (..) (AU)


Calciphylaxis is an uncommon but serious disease process that affects mainly patients with advanced renal failure. Calciphylaxis is characterized by dermal arteriolar calcification that leads to skin ulceration, necrosis, ischemia and secondary infection. The pathogenesis is poorly understood, although the calcium phosphorus product has been proposed as a major cause. Given the high morbidity and mortality rate, emphasis should be placed on prevention and early diagnosis of vascular calcification, as well as in prophylaxis of secondary infection. We (..) (AU)


Assuntos
Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Idoso , Calciofilaxia/diagnóstico , Insuficiência Renal Crônica/complicações , Diálise/efeitos adversos , Arteriolosclerose/diagnóstico , Cálcio/sangue , Fósforo/sangue , Hiperparatireoidismo Secundário/prevenção & controle , Obesidade/complicações
6.
Eur J Clin Pharmacol ; 55(1): 35-41, 1999 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-10206082

RESUMO

BACKGROUND: General anaesthetics inhibit mitochondrial function in animal models. However, very few studies have been performed in humans, and the results have not been conclusive. METHODS: We prospectively studied the oxygen consumption and the individual enzyme activity of each complex of the mitochondrial respiratory chain of skeletal muscle mitochondria in 54 healthy individuals who underwent general anaesthesia for orthopaedic surgery. The control group (n = 54) was made up of individuals submitted to the same orthopaedic procedure under regional anaesthesia (n = 31), and patients who underwent muscle biopsies for diagnostic purposes by local anaesthesia (n = 23). RESULTS: We found a significant decrease in the oxidation of glutamate (-36%), succinate (-25%) and ascorbate (-29%) in the general anaesthetic group compared with the controls (P < 0.001 for all substrates). The level of such inhibition was similar for volatile anaesthetics with strong (halothane) or weak (isoflurane) negative inotropic effect. By contrast, the enzymatic activity of all individual complexes and the coupling of oxidative phosphorylation did not differ between the two groups. CONCLUSION: We conclude that during general anaesthetic procedures there is an extensive inhibition of substrate oxidation in human muscle mitochondria, and that it is not caused by a direct effect on complexes of the mitochondrial respiratory chain or through uncoupling oxidative phosphorylation.


Assuntos
Anestésicos Inalatórios/efeitos adversos , Mitocôndrias Musculares/efeitos dos fármacos , Músculo Esquelético/efeitos dos fármacos , Oxirredutases/metabolismo , Anestesia por Condução/efeitos adversos , Anestesia Local/efeitos adversos , Ácido Ascórbico/metabolismo , Feminino , Ácido Glutâmico/metabolismo , Halotano/efeitos adversos , Humanos , Técnicas In Vitro , Isoflurano/efeitos adversos , Masculino , Pessoa de Meia-Idade , Mitocôndrias Musculares/enzimologia , Mitocôndrias Musculares/metabolismo , Músculo Esquelético/enzimologia , Músculo Esquelético/metabolismo , Espectrofotometria , Ácido Succínico/metabolismo
7.
J Ethnopharmacol ; 62(2): 107-15, 1998 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-9741882

RESUMO

The activities of crude plant extracts of five plants popularly used in Guatemala against bacterial and protozoal infections and some of their fractions have been evaluated against the trypomastigote and epimastigote forms of Trypanosoma cruzi in vitro. The most active fraction of Neurolaena lobata has also been screened in vivo. Main in vitro activities against trypomastigotes have been observed for the hexane and ethanol extracts of N. lobata (Asteraceae). Both extracts were also active against epimastigotes, whereas all other extracts tested had no effect on epimastigotes. For the hexane extracts of Petiveria alliacea (Phytolaccaceae) and Tridax procumbens (Asteraceae) a marked inhibition of trypomastigotes has been found. Also the ethanol extracts of Byrsonima crassifolia (Malpighiaceae) leafs and Gliricidia sepium (Papilionaceae) bark showed some trypanocidal activity. Fraction 2 of the ethanol extract of N. lobata was highly active against T. cruzi as well in vitro as in vivo. The chloroforme fraction of P. alliacea showed a high inhibition of trypomastigotes in vitro. Also three fractions of the active extract of B. crassifolia inhibited T. cruzi trypomastigotes. No fraction of G. sepium bark extract showed a marked trypanocidal activity.


Assuntos
Extratos Vegetais/uso terapêutico , Plantas Medicinais/química , Tripanossomicidas/uso terapêutico , Trypanosoma cruzi/efeitos dos fármacos , Tripanossomíase/tratamento farmacológico , Animais , Guatemala , Extratos Vegetais/farmacologia , Tripanossomicidas/isolamento & purificação , Tripanossomíase/parasitologia
9.
Rev Esp Fisiol ; 35(1): 29-35, 1979 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-461907

RESUMO

Eleven patients with different degrees of renal failure with creatinine clearances between 7 and 32 ml/min have been studied. After a standard water overload and control periods of clearances, furosemide 1 g was given/i.v. There followed significant increase of renal plasma flow and glomerular filtration rate. In one case the increase was maintained during a follow up period of 3 hours. A significant increase was evident in phosphate, uric acid, sodium, potassium, and calcium clearances, as well as an increase in the sodium delivery to the distal nephron and a decrease in tubular reabsorption of phosphate. All this may be interpreted as the result of renal vasodilation induced by furosemide and its effect upon the proximal tubule and on Henle's loop.


Assuntos
Circulação Sanguínea/efeitos dos fármacos , Furosemida/farmacologia , Taxa de Filtração Glomerular/efeitos dos fármacos , Falência Renal Crônica/tratamento farmacológico , Rim/irrigação sanguínea , Relação Dose-Resposta a Droga , Furosemida/administração & dosagem , Humanos , Injeções Intravenosas
10.
Arch Intern Med ; 137(9): 1217, 1977 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-901091

RESUMO

After washing his hair with diesel fuel a 28-year-old patient developed acute renal failure (ARF) and oliguria requiring hemodialysis. The patient recuperated completely. In the absence of other causal factors, we believe that the absorption of the diesel fuel components, either through the respiratory tract or through the skin can be considered to be the cause of the ARF. In spite of the extended everyday use of petroleum distillation products, cases of acute intoxication are infrequent. Even rarer are cases in which these products occasion ARF.


Assuntos
Injúria Renal Aguda/induzido quimicamente , Óleos Combustíveis/intoxicação , Petróleo/intoxicação , Adulto , Humanos , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA